RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Deltex Medical Group - Stock

Deltex Medical Group ROE 2024

Deltex Medical Group ROE

-0.39

Ticker

DEMG.L

ISIN

GB0059337583

WKN

927020

In 2024, Deltex Medical Group's return on equity (ROE) was -0.39, a -20.03% increase from the -0.49 ROE in the previous year.

Deltex Medical Group Aktienanalyse

What does Deltex Medical Group do?

Deltex Medical Group PLC is a leading provider of anesthesia, intensive care, and emergency medicine monitoring products. The company develops and produces products for patient monitoring during anesthesia and cardiovascular system monitoring. Additionally, Delta Medical offers training for healthcare professionals. The company specializes in developing and producing products that enable real-time monitoring of blood flow and fluid volume. These products are primarily designed for use in anesthesia, intensive care, and emergency medicine. The technology allows medical professionals to improve both patient care and process efficiency. Deltex Medical operates in the anesthesia, intensive care, and emergency medicine industries. Each industry has specific patient monitoring requirements, and Deltex Medical offers specialized products for each area. For example, anesthesia products focus on monitoring fluid volume and blood flow during anesthesia. Intensive care products continuously measure fluid volume and blood flow in patients with severe illnesses or injuries. Deltex Medical's emergency medicine products enable rapid patient monitoring in acute medical situations. Some of Deltex Medical's products include the CardioQ-ODM+ and the TrueVue system for monitoring cardiovascular functions and vital signs. The CardioQ-ODM+ is a non-invasive system designed for anesthesia, intensive care, and emergency medicine patients. The TrueVue system is an invasive system used during surgeries and in intensive care to monitor blood flow and fluid volume in real-time. Both systems provide real-time data that allows for quick and accurate adjustments to patient care. Deltex Medical also offers training for healthcare professionals to ensure optimal use of the systems. The training is aimed at anesthesiologists, intensivists, and emergency medicine physicians, covering both theory and practical application of the systems. The training can be conducted online or in-person. In 2011, Deltex Medical received a significant award for its work in anesthesia monitoring. The Technology Industry Award praised the company for its continuous innovation and mission to improve clinical practice. In summary, Deltex Medical Group PLC is a leading provider of anesthesia, intensive care, and emergency medicine monitoring products. The company has a wide product portfolio that includes both invasive and non-invasive systems. Additionally, Deltex Medical offers training to ensure optimal use of the systems by healthcare professionals. With its technical expertise and commitment to clinical practice, Deltex Medical Group PLC has become a valuable partner in the healthcare industry. Deltex Medical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Deltex Medical Group's Return on Equity (ROE)

Deltex Medical Group's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Deltex Medical Group's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Deltex Medical Group's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Deltex Medical Group’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Deltex Medical Group Stock

What is the ROE (Return on Equity) of Deltex Medical Group this year?

The ROE of Deltex Medical Group this year is -0.39 undefined.

How has the Return on Equity (ROE) of Deltex Medical Group developed compared to the previous year?

The ROE of Deltex Medical Group has increased by -20.03% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Deltex Medical Group?

A high ROE indicates that Deltex Medical Group generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Deltex Medical Group?

A low ROE can indicate that Deltex Medical Group is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Deltex Medical Group affect the company?

A change in ROE (Return on Equity) of Deltex Medical Group can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Deltex Medical Group?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Deltex Medical Group?

Some factors that can influence Deltex Medical Group's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Deltex Medical Group pay?

Over the past 12 months, Deltex Medical Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Deltex Medical Group is expected to pay a dividend of 0 GBP.

What is the dividend yield of Deltex Medical Group?

The current dividend yield of Deltex Medical Group is .

When does Deltex Medical Group pay dividends?

Deltex Medical Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Deltex Medical Group?

Deltex Medical Group paid dividends every year for the past 0 years.

What is the dividend of Deltex Medical Group?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Deltex Medical Group located?

Deltex Medical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Deltex Medical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Deltex Medical Group from 6/24/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 6/24/2024.

When did Deltex Medical Group pay the last dividend?

The last dividend was paid out on 6/24/2024.

What was the dividend of Deltex Medical Group in the year 2023?

In the year 2023, Deltex Medical Group distributed 0 GBP as dividends.

In which currency does Deltex Medical Group pay out the dividend?

The dividends of Deltex Medical Group are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Deltex Medical Group

Our stock analysis for Deltex Medical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Deltex Medical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.